// App-Quantinova.ai

1208 : DE‐labelling beta‐lactam allergy using telemedicine and single dose oral challenge in a low risk paediatric cohort: Outcome of DE‐labelling process one year later

Researchers

Presenter

  • Allen HI

Principal Investigators

  • Vazquez-Ortiz M

  • Murphy AW

  • Moylett EM

Medical Centers

  • Galway University Hospital, Galway, Ireland

  • The National University of Ireland, Galway, Ireland

  • Spiddal Medical Centre, Galway, Ireland

  • Imperial College, London, United Kingdom

Locations

  • Ireland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • C1 Inhibitor Deficiency

  • Anxiety

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved